China’s NHSA and MOF Issue Notices to Enhance Cross-Regional Medical Treatment Direct Settlement
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MOF) have issued two...
CDE Launches CARE Plan to Streamline Rare Disease Drug Development
The Center for Drug Evaluation has unveiled the ‘Pilot Work Plan for Patient-Centered Action for...
Moderna Inc. Announces Cost-Cutting Measures and Pipeline Realignment
Moderna Inc. (NASDAQ: MRNA), a leading mRNA technology company based in the U.S., has announced...
Sino Biological and BioGeometry Broaden Partnership to Advance AI-Driven Drug Discovery
Sino Biological (SHE: 301047), a leading biotech company in China, and BioGeometry have announced an...
Johnson & Johnson Submits Second NDA for Nipocalimab to Treat Generalized Myasthenia Gravis
Johnson & Johnson (NYSE: JNJ), a leading healthcare company based in the U.S., has reported...
Keymed Biosciences’ IL-4Rα mAb Stapokibart Receives NMPA Approval for Atopic Dermatitis Treatment
Keymed Biosciences Inc. (HKG: 2162), a biopharmaceutical company based in China, has announced that the...
South Korea’s MFDS Aims to Slash Drug Approval Times with New Innovation Plan
South Korea’s Ministry of Food and Drug Safety (MFDS) has unveiled an ambitious plan to...
Alibaba Health Forges Strategic Partnerships with Viatris and Chinese Pharma Companies for Digital Health Expansion
Alibaba Health Information Technology Ltd (HKG: 0241), the health industry arm of Chinese e-commerce giant...
Shanghai Bao Pharmaceutical and Subsidiary Secure Commercialization Rights Deal for SJ02 with Organon China
Shanghai Bao Pharmaceutical, a Chinese pharmaceutical company, along with its wholly-owned subsidiary Suzhou Centergene Pharmaceuticals,...
ChemPartner Pharmatech Enters Strategic Partnership with Malaysian Entities to Develop Innovative Drugs
ChemPartner Pharmatech Co., Ltd (SHE: 300149), a leading pharmaceutical company based in China, has joined...
Nona Biosciences and Umoja Biopharma Join Forces to Develop In Vivo CAR-T Therapies
Nona Biosciences, a subsidiary of HBM Holdings Ltd (HKG: 2142), has entered into a strategic...
Beijing’s MoleculeMind Secures Series A Funding to Accelerate AI Protein Design Innovations
MoleculeMind, a Beijing-based AI protein design platform, has reportedly secured a Series A financing round,...
Leadership Shuffle at China’s National Health Commission: Liu Jinfeng Steps in as Deputy Director
The Ministry of Human Resources and Social Security has announced key leadership changes within the...
Autobio Diagnostics Partners with MBL to Advance Microbial Mass Spectrometry Technology
Autobio Diagnostics Co., Ltd (SHA: 603658), a prominent player in China’s in vitro diagnostic market,...
Yestar Healthcare’s 2024 Interim Report Reflects Impact of Volume-Based Procurement on Revenue
Yestar Healthcare Holdings Co., Ltd., a leading distributor and service provider for in vitro diagnostic...
Sanofi’s Dupixent Shows Promise in Phase III Trials for Rare Skin Disease and Chronic Hives
Sanofi (EPA: SAN; NASDAQ: SNY), a leading French pharmaceutical company, has announced positive results from...
FDA Uncovers Data Management Failures in Medical Device Labs, Assessing Regulatory Impact
Medical device manufacturers relying on laboratory services for testing and validation data have come under...
Oxford Nanopore Sets Sights on BGI in UK Courts Over Nanopore Sequencing Technology
Oxford Nanopore Technologies plc (LON: ONT), a UK-based leader in nanopore sequencing technology, has disclosed...
Luye Pharma’s Subsidiary Boan Biotech Partners with Haier Biomedical for Pharmaceutical Industry Digitalization
Luye Pharma Group (HKG: 2186), a leading pharmaceutical company based in China, has announced a...
Signet Therapeutics and Jennio Biotech Join Forces to Advance Tumor Immunotherapy
Signet Therapeutics, a pioneering biopharmaceutical company in China specializing in cancer targeted therapies based on...